3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Neuroendocrine Tumors
2
Vaginal Neoplasms
1
Lymphoma, Follicular
1
Glioblastoma
1
Endometrial Serous Adenocarcinoma
1
Astrocytoma
1
Interventions
cabozantinib
4
Surveys and Questionnaires
2
Nivolumab
2
Ipilimumab
2
zimberelimab
1
temsirolimus
1
salicylhydroxamic acid
1
orellanine
1
brodalumab
1
belzutifan
1
atezolizumab
1
Ropivacaine
1
Radionuclide Imaging
1
Pluvicto
1
Patient Reported Outcome Measures
1
Methods
1
Magnetic Resonance Imaging
1
Health Promotion
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Everolimus
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Dacarbazine
1
Counseling
1
Blood Component Removal
1
Axitinib
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
30 days
×
Clear all
No trials found.